Top Tip: Mining Multibagger, Ready to Run

U.S. junior critical mineral miner, ARES STRATEGIC MINING (CSE: ARS | FRA: N8I1 | OTC: ARSMF), is about to have its long-awaited Cinderella moment.
For 5 years now, ARES has owned the only permitted fluorspar mine in the U.S. out of Delta, Utah. They’ve been drilling, fund-raising and constructing facilities, all the while hoping someone would notice. Following the recent outpouring of $11M in State support and funding, ARES is now just inches away from announcing first revenues.

Insatiable demand for an unsung hero
Never heard of Fluorspar? Most haven’t. And yet this unsung hero is essential to hi-tech manufacturing, including semiconductors and very likely, the device you’re reading this article on. In fact, its applications are often within an arms reach, at all times.

Billion-dollar U.S. industries have an insatiable demand for fluorspar, and yet, it is currently 100% imported, from China and other volatile regions.
It’s little wonder a U.S. government who seeks mineral security like never before, has backed ARES to go all the way!
A rare event
ARES is attracting significant attention from individual and institutional investors, as the company is about to extract initial ore from its Lost Sheep Mine.
And the kicker? Plans are approved to extract a second critical mineral found at the same site: Gallium.
Two for the price of one
Gallium, another designated U.S. critical mineral becoming a household name, is used extensively in semiconductors, fiber optics, and military applications.

ARES is actively collaborating with the U.S. Department of Energy’s affiliated Ames National Laboratory to develop methods of extracting gallium as a byproduct of fluorspar processing.
This positions the company to deliver two critical minerals from a single U.S. operation.
Reasons to invest now
It’s not every day that investors see a rare, low-risk chance to put your money into a homegrown company on the cusp of explosive growth.
Although it’s taken them over 5 years, to their credit, ARES has hung on through various funding routes and trials. For some long-term shareholders, 5 years has felt like an eternity and they’ve sold up. For many others, they are holding firm, determined to see this Cinderella at the ball.
For penny stock traders, or astute investors who recognize the value of getting in at exactly the right time, this one is for you.
Forecasted Production 54K tons acidspar/ year, 300K tons over 5 years 6K tons metspar/ year, 30K tons over 5 years Forecasted Revenue $29M in year 1, $145M over 5 years
Wall Street Endeavor has a disclosure policy. Please note this article is for informational purposes and does not constitute financial advice. Always conduct your own due diligence before investing.




Comments